A compact platform reduces the cost and infrastructure typically required for advanced genomics research, expanding access for startups, academic and incubator labs, and enterprise R&D teams.

Beverly, MA – RAN Biotechnologies, a science-driven innovator in advanced micro- and nano-materials and microfluidic systems, today announced the launch of the OrchestRANum™ System, a new line of products designed to make high- performance single-cell partitioning accessible, flexible, and cost-effective for research laboratories worldwide. The system is engineered to support workflows such as single-cell RNA sequencing (scRNA-seq), a cornerstone technology in modern biology and precision medicine.

The OrchestRANum™ System combines optimized hardware, consumables, and flexible protocols to deliver reliable, customizable, and rapid single-cell partitioning into barcode droplets (BARDs™) compatible with standard molecular biology workflows. Its two scalable introductory kits support sample inputs from 5,000 to 80,000 cells and ensure broad utility across diverse scRNA-seq applications.

“The OrchestRANum™ System was born from our core belief that scientists deserve tools that are both smart and affordable,” said Dr. Roger Nassar, Founder and CEO of RAN Biotechnologies. “As researchers ourselves, we know that high barriers to entry in microfluidics and single-cell analysis slow scientific progress. With OrchestRANum™, we’re changing that by offering a platform that works reliably out of the box yet is flexible enough to adapt to the needs of today’s research.”

A System Built for Scientists by Scientists

RAN Biotechnologies draws on its roots in MIT-driven research and decades of expertise in microfluidics and material science to deliver a platform that prioritizes the real-world needs of the research community. The OrchestRANum™ System reflects RAN Biotech’s ongoing commitment to democratizing access to sophisticated biological assays, enabling laboratories of all sizes to harness the power of single-cell technologies.

Part of a Growing Suite of Microfluidic Innovations

The OrchestRANum™ System complements RAN Biotech’s expanding product portfolio, including fluorosurfactants, fluorinated oils, fluorinated surface coatings, PFAS-free surfactants and surface coatings, aqueous recovery oils, barcode gel beads, microfluidic chips, pump-flow controller combinations, and chip-free microfluidic kits. Together, these offerings provide end-to-end support for labs developing next-generation tools in genomics, single-cell analysis, therapeutics, and environmental science.

To learn more about the OrchestRANum™ System, visit: www.ranbiotechnologies.com/products/orchestranum-system/.

About RAN Biotechnologies

RAN Biotechnologies is a specialty biochemical and device company focused on developing intelligent materials and enabling technologies used in modern scientific research. Founded in 2012 on research conducted at MIT and headquartered in the greater Boston area, the company serves markets including biopharmaceutical development, personalized medicine, environmental monitoring, and academic research. For more information, visit www.ranbiotechnologies.com.